ClinicalTrials.Veeva

Menu

Study of the Glycocalyx in Abdominal Aortic Aneurysm (Endo_eAAA)

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Surgery
Ischemic Reperfusion Injury
Abdominal Aortic Aneurism

Treatments

Other: Plasma

Study type

Interventional

Funder types

Other

Identifiers

NCT01834092
H-4-2012-085

Details and patient eligibility

About

The investigators want to measure the degradation of the endothelial glycocalyx before and after clamping the aorta, in patients operated for a abdominal aortic aneurism.

Full description

50 patients is scheduled for enrollment. Blood samples will be up taken before surgery, 10 min after reperfusion, at the end of surgery and the following morning. In addition the investigators are placing a renal venous catheter where blood samples will be up taken as mentioned above for the analysis of endothelial markers together with markers for kidney damage.

The first 10 patient will act as part of a pilot study, where only measurement of the endothelial and renal failure markers will be performed.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • above 18 years

Exclusion criteria

  • prior engagement in scientific study within the last 30 days.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Fresh frozen plasma
Active Comparator group
Description:
2 portions of FFP will be transfused prior to reperfusion
Treatment:
Other: Plasma
Fresh non-frozen plasma
Experimental group
Description:
2 portions of non-frozen plasma will be transfused prior to reperfusion
Treatment:
Other: Plasma

Trial contacts and locations

1

Loading...

Central trial contact

Thomas B Jørgensen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems